Related Experiment Video
Updated: May 13, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations
D Lin1, Q Kamili, K Qurat-Ul-Ain
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. derekl@bcm.edu
Abstract:
We present a case of cerebral Scedosporium apiospermum infection presenting with intestinal manifestations in a 64-year-old male patient on immunosuppression for orthotopic liver transplantation. At admission, the patient's chief complaint was chronic watery diarrhea and he was found to have colonic ulcers on endoscopy. His hospital course was complicated by a tonic-clonic seizure caused by a left frontal brain abscess, with the causative agent being identified by culture. He was treated with lobectomy, high-dose intravenous voriconazole, and liposomal amphotericin with clinical, endoscopic, and histologic improvement. To our knowledge, S. apiospermum has not been previously described as a cause of colitis. The septate branching appearance of the Scedosporium species is similar to the more common Aspergillus species. This case of gastrointestinal Scedosporium brings into question previously reported cases of isolated gastrointestinal aspergillosis diagnosed by histopathology. Clinical suspicion for S. apiospermum must be maintained in immunosuppressed patients presenting with neurologic and gastrointestinal symptoms.
Insights
Scedosporium apiospermum, a fungal infection, can cause brain abscesses and colitis in immunosuppressed patients, particularly after liver transplants. Early diagnosis and treatment are crucial for managing this rare but serious condition.
Area of Science:
- Mycology
- Infectious Diseases
- Transplantation Medicine
Background:
- Scedosporium apiospermum is an opportunistic mold.
- Immunosuppression, particularly after organ transplantation, increases susceptibility to fungal infections.
- Cerebral and gastrointestinal fungal infections are serious complications in immunocompromised individuals.
Observation:
- A 64-year-old liver transplant recipient presented with chronic diarrhea and colonic ulcers.
- The patient developed a seizure due to a left frontal brain abscess.
- Cultures identified Scedosporium apiospermum as the causative agent for both cerebral and gastrointestinal symptoms.
Findings:
- This case describes Scedosporium apiospermum causing both cerebral and intestinal disease, a presentation not previously documented.
- The fungal morphology is similar to Aspergillus, potentially leading to misdiagnosis in histopathology.
- Successful treatment involved surgery, voriconazole, and liposomal amphotericin.
Implications:
- Scedosporium apiospermum should be considered in immunosuppressed patients with combined neurological and gastrointestinal symptoms.
- This case highlights the need for careful histopathological review to differentiate Scedosporium from Aspergillus.
- The findings expand the known clinical spectrum of Scedosporium apiospermum infections.
Related Concept Videos
Fungal Phylum Microsporidia
Brain Abscess l: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Diversity of Protists II
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Clinical Manifestations
